Exacerbation of IgA nephropathy in a patient receiving dupilumab.

Yamamoto, Masako; Kawase, Yuriko; Nakajima, Emi; Matsuura, Yoshiaki; Akita, Wataru; Aoki, Ryousuke; Suzuki, Yusuke; Mitsui, Hiroshi

Yamamoto, Masako; Kawase, Yuriko; Nakajima, Emi; Matsuura, Yoshiaki; Akita, Wataru; Aoki, Ryousuke; Suzuki, Yusuke; Mitsui, Hiroshi.

Afiliação

Yamamoto M; Department of Dermatology, Fraternity Memorial Hospital, Tokyo, Japan.
Kawase Y; Department of Dermatology, Fraternity Memorial Hospital, Tokyo, Japan.
Nakajima E; Department of Nephrology, Fraternity Memorial Hospital, Tokyo, Japan.
Matsuura Y; Department of Nephrology, Fraternity Memorial Hospital, Tokyo, Japan.
Akita W; Department of Nephrology, Fraternity Memorial Hospital, Tokyo, Japan.
Aoki R; Department of Nephrology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Suzuki Y; Department of Nephrology, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Mitsui H; Department of Dermatology, Tokyo Teishin Hospital, Tokyo, Japan.

JAAD Case Rep ; 21: 150-153, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35242969

Palavras-chave

AD, atopic dermatitis; Gd-IgA1, undergalactosylated IgA1; IL, interleukin; IgA nephropathy; IgA-N, IgA nephropathy; RF, rheumatoid factor; TLR, toll-like receptor; Th, helper T; atopic dermatitis; dupilumab; renal dysfunction; toll-like receptor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article